Nuclear transcription factor Y subunit gamma (28-37)

Nuclear transcription factor Y subunit gamma (28-37) is a synthetic peptide fragment derived from the gamma subunit of the NF-Y transcription factor complex, specifically encompassing amino acid residues 28 to 37. As an integral component of the heterotrimeric NF-Y complex, the gamma subunit plays a pivotal role in the regulation of gene expression through its involvement in the recognition and binding of CCAAT motifs within promoter regions. This peptide segment is frequently utilized in molecular biology and biochemical research to elucidate the structure-function relationships of transcription factors, investigate protein-protein and protein-DNA interactions, and serve as a tool for dissecting the molecular mechanisms underlying transcriptional regulation.

Peptide-Protein Interaction Studies: The 28-37 fragment of the NF-Y gamma subunit is commonly employed to investigate the specific molecular interactions between NF-Y components and their binding partners. By utilizing this defined sequence, researchers can delineate the contribution of the gamma subunit's central domain to the assembly and stability of the NF-Y complex. Such studies are essential for understanding how alterations in subunit interactions may influence transcriptional activity and gene regulatory networks in eukaryotic cells.

Transcriptional Regulation Mechanism Analysis: Researchers frequently use this peptide in assays designed to probe the mechanisms by which the NF-Y complex recognizes and binds to CCAAT box elements in DNA. The defined sequence allows for targeted mutagenesis, competition assays, and affinity measurements, providing insight into the sequence-specific determinants of DNA binding and the role of the gamma subunit in modulating transcription factor specificity and affinity.

Epitope Mapping and Antibody Development: The peptide corresponding to residues 28-37 of the NF-Y gamma subunit serves as a valuable antigen for generating sequence-specific antibodies. These antibodies can be used in immunoassays, such as Western blotting and immunoprecipitation, to detect the presence, abundance, or post-translational modifications of the gamma subunit in cellular extracts. Additionally, epitope mapping with this peptide aids in characterizing antibody specificity and optimizing immunodetection strategies for NF-Y-related studies.

Peptide-Based Functional Assays: In cellular and in vitro systems, the synthetic peptide may be introduced to assess its impact on NF-Y complex formation, transcriptional activation, or competitive inhibition of endogenous protein interactions. Such functional assays enable researchers to dissect the contribution of the gamma subunit's central domain to gene expression regulation, facilitating the identification of potential modulatory sites or interaction hot spots within the complex.

Structural and Biophysical Characterization: The defined sequence of the 28-37 peptide supports advanced structural studies, including nuclear magnetic resonance (NMR) spectroscopy, circular dichroism, and molecular modeling. These approaches help elucidate the secondary structure propensity, conformational dynamics, and interaction surfaces of the gamma subunit fragment, providing a foundation for rational design of peptide mimetics or inhibitors targeting the NF-Y complex. Through such analyses, the peptide advances our understanding of transcription factor architecture and its implications for gene regulatory mechanisms.

1. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

2. Implications of ligand-receptor binding kinetics on GLP-1R signalling

3. Myotropic activity of allatostatins in tenebrionid beetles

4. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction